Back to News
Market Impact: 0.2

Validea Detailed Fundamental Analysis

GILDNDAQ
Company FundamentalsCapital Returns (Dividends / Buybacks)Analyst InsightsHealthcare & Biotech
Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates Gilead Sciences (GILD), a large-cap biotechnology stock, scores 75% on Meb Faber's Shareholder Yield Investor model, falling below the 80% threshold for 'some interest'. Notably, GILD failed the critical 'Net Payout Yield' and 'Shareholder Yield' tests within this cash-return-focused strategy, despite passing on valuation, quality/debt, and relative strength.

Analysis

According to a Validea fundamental report, Gilead Sciences, Inc. (GILD) exhibits a mixed profile under Meb Faber's Shareholder Yield Investor model. The company, a large-cap growth stock in the biotechnology sector, achieved a score of 75%, which falls below the 80% threshold that typically signifies initial interest for this specific strategy. While GILD passed tests related to its valuation, quality and debt structure, and relative strength, it critically failed on the core criteria of 'Net Payout Yield' and 'Shareholder Yield'. This indicates that despite other fundamental strengths, the company's current efforts in returning cash to shareholders through dividends, buybacks, and debt reduction are not robust enough to meet the high standards of this particular quantitative screen. The overall neutral sentiment score of 0.0 reflects this dichotomy, suggesting the positive factors are offset by the primary weakness in cash returns.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

0.00

Ticker Sentiment

GILD0.10
NDAQ0.00

Key Decisions for Investors

  • Investors strictly focused on shareholder yield strategies should view GILD with caution, as its failure on the model's core 'Net Payout Yield' criterion suggests it is not a top-tier candidate for this mandate.
  • Given that GILD passed on 'Valuation' and 'Quality and Debt', value-oriented or quality-focused investors may find the stock worthy of further due diligence, provided that high direct cash returns are not their primary investment objective.
  • The 75% score positions GILD as a borderline case rather than a high-conviction opportunity under this model, warranting a review of its position size for those who hold it based on its yield characteristics.